MX2013001447A - Metodo de produccion y purificacion de una sialiltransferasa soluble activa. - Google Patents

Metodo de produccion y purificacion de una sialiltransferasa soluble activa.

Info

Publication number
MX2013001447A
MX2013001447A MX2013001447A MX2013001447A MX2013001447A MX 2013001447 A MX2013001447 A MX 2013001447A MX 2013001447 A MX2013001447 A MX 2013001447A MX 2013001447 A MX2013001447 A MX 2013001447A MX 2013001447 A MX2013001447 A MX 2013001447A
Authority
MX
Mexico
Prior art keywords
sialyltransferase
polypeptide
purifying
producing
active soluble
Prior art date
Application number
MX2013001447A
Other languages
English (en)
Spanish (es)
Inventor
Axel Angermann
Christian Scheckermann
Karsten Schmidt
Original Assignee
Biogenerix Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogenerix Gmbh filed Critical Biogenerix Gmbh
Publication of MX2013001447A publication Critical patent/MX2013001447A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1081Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/99Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C12Y204/99003Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase (2.4.99.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2013001447A 2010-08-02 2011-08-02 Metodo de produccion y purificacion de una sialiltransferasa soluble activa. MX2013001447A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20100171626 EP2415779B1 (en) 2010-08-02 2010-08-02 Method of producing and purifying an active soluble sialyltransferase
PCT/EP2011/063291 WO2012016984A1 (en) 2010-08-02 2011-08-02 Method of producing and purifying an active soluble sialyltransferase

Publications (1)

Publication Number Publication Date
MX2013001447A true MX2013001447A (es) 2013-11-20

Family

ID=42736163

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013001447A MX2013001447A (es) 2010-08-02 2011-08-02 Metodo de produccion y purificacion de una sialiltransferasa soluble activa.

Country Status (9)

Country Link
US (1) US9222081B2 (enExample)
EP (2) EP2415779B1 (enExample)
JP (1) JP5984267B2 (enExample)
CN (1) CN103154017B (enExample)
CA (1) CA2807397C (enExample)
ES (1) ES2534936T3 (enExample)
MX (1) MX2013001447A (enExample)
PT (1) PT2415779E (enExample)
WO (1) WO2012016984A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
SG11201505193SA (en) * 2013-02-06 2015-08-28 Agency Science Tech & Res Mixed multifunctional metal affinity surfaces for reducing aggregate content in protein preparations
TWI631132B (zh) 2013-05-06 2018-08-01 賽諾菲公司 用於純化抗體之連續多步驟方法
HK1243329A1 (zh) * 2015-03-31 2018-07-13 Yeda Research And Development Co., Ltd. 谷氨酸草酰乙酸转氨酶1(got1)、其制剂、产生方法及用途
KR101667677B1 (ko) * 2015-05-29 2016-10-19 한국생명공학연구원 재조합 ST6Gal1 단백질을 활성형으로 제조하는 방법
EP3559249A1 (en) 2016-12-21 2019-10-30 H. Hoffnabb-La Roche Ag Method for in vitro glycoengineering of antibodies
MX2019007411A (es) 2016-12-21 2019-08-29 Hoffmann La Roche Reuso de enzimas en glucomanipulacion in vitro de anticuerpos.
KR102229037B1 (ko) 2017-09-04 2021-03-17 89바이오 리미티드 돌연변이 fgf-21 펩티드 접합체 및 이의 용도
WO2019063849A1 (en) * 2017-12-20 2019-04-04 Dsm Ip Assets B.V. PURIFICATION OF A POLYPEPTIDE OF INTEREST
EP3546475A1 (en) 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
KR102362777B1 (ko) * 2018-03-27 2022-02-15 주식회사 녹십자 친화성 크로마토그래피 공정을 포함하는 백일해균 유래 단백질 수득 방법
KR102140531B1 (ko) * 2018-08-07 2020-08-04 (주)휴온스 Gly-Tβ4의 제조방법
DK3613486T3 (da) * 2018-08-24 2021-01-04 Uga Biopharma Gmbh Metode og anlæg til rengøring af epo og/eller et epo-derivat
CN113416243B (zh) * 2021-08-23 2021-12-10 上海盛迪医药有限公司 一种纯化抗体的方法
CN119912505A (zh) * 2025-04-02 2025-05-02 浙江熙正霖生物科技有限公司 一种从发酵液中提纯唾液酸的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032519A (en) 1989-10-24 1991-07-16 The Regents Of The Univ. Of California Method for producing secretable glycosyltransferases and other Golgi processing enzymes
WO1995018217A1 (en) 1993-12-24 1995-07-06 The Institute Of Physical And Chemical Research Novel sugar-chain synthetase and process for producing the same
US6280989B1 (en) * 1999-06-17 2001-08-28 Dmitri Kapitonov Sialyltransferases
EP2042196B1 (en) 2001-10-10 2016-07-13 ratiopharm GmbH Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
WO2005055946A2 (en) * 2003-12-03 2005-06-23 Neose Technologies, Inc. Glycopegylated granulocyte colony stimulating factor
US20080206810A1 (en) 2004-06-03 2008-08-28 Neose Technologies, Inc. Truncated St6galnaci Polypeptides and Nucleic Acids
WO2006102652A2 (en) 2005-03-24 2006-09-28 Neose Technologies, Inc. Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
EP1866427A4 (en) * 2005-03-30 2010-09-01 Novo Nordisk As METHOD OF MANUFACTURING PEPTIDES PRODUCED IN INSECT CELL LINES
WO2007056524A2 (en) 2005-11-09 2007-05-18 Neose Technologies, Inc. St3gal-1/st6galnac-1 chimeras
US8969532B2 (en) * 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
US20080207487A1 (en) 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines

Also Published As

Publication number Publication date
CN103154017A (zh) 2013-06-12
CA2807397A1 (en) 2012-02-09
PT2415779E (pt) 2015-05-13
US9222081B2 (en) 2015-12-29
CA2807397C (en) 2019-03-19
WO2012016984A1 (en) 2012-02-09
EP2601207B1 (en) 2016-12-28
EP2601207A1 (en) 2013-06-12
JP5984267B2 (ja) 2016-09-06
ES2534936T3 (es) 2015-04-30
JP2013535207A (ja) 2013-09-12
US20140057316A1 (en) 2014-02-27
EP2415779B1 (en) 2015-01-21
CN103154017B (zh) 2016-02-03
EP2415779A1 (en) 2012-02-08

Similar Documents

Publication Publication Date Title
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
SG178925A1 (en) Process for producing molecules containing specialized glycan structures
WO2014028453A3 (en) Natural killer cells and uses thereof
PH12013500820B1 (en) Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli
SG10201805291TA (en) Production of heterodimeric proteins
WO2013152051A3 (en) Improved production of fatty acid derivatives
MY161726A (en) Biological methods for preparing adipic acid
UA107678C2 (uk) Процес очищення рекомбінантного людського еритропоетину (епо), епо, очищений таким чином, та фармацевтична композиція, що містить його
AR087433A1 (es) Analogos de insulina n-glicosilados
MY198086A (en) Method for producing substituted 5-fluoro-1h-pyrazolopyridines
EP2452931A4 (en) PROCESS FOR THE PREPARATION OF TRICYCLIC DERIVATIVES
BR112013001179A2 (pt) sacrificação e fermentação em ph neutro.
BR112015005416A2 (pt) produção de ácidos orgânicos por meio de fermentação em baixo ph
EP4458858A3 (en) Method for the production of immunoglobulin single variable domains
PH12012501438A1 (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
MY184072A (en) Increasing virus like particle yield in plants
PH12014502004A1 (en) An improved process for preparation of physiologically active polypeptide complex
BR112014014762A8 (pt) método para preparação de cisteína ou de um derivado desta usando uma nova o-fosferina sulfidrilase
MX2010005015A (es) Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero.
PH12013500378A1 (en) Novel succinic acid-producing mutant microorganism that utilizes sucrose and glycerol simultaneously and method for producing succinic acid using the same
MY155284A (en) Process for the preparation of ajoene
MX2010001864A (es) Metodo para la preparacion de acido montelukast en un medio liquido ionico.
MX2007010141A (es) Procesos para la preparacion de intermedios de linezolid.
EA201301294A1 (ru) Получение высокочистых мультисубъединичных белков, таких как антитела, в трансформированных микроорганизмах, например pichia pastoris
WO2011107843A3 (en) Process for the preparation of atazanavir sulfate substantially free of diastereomers